Posted in Detoxification by admin - Feb 29 2012
Posted in Healthcare by admin - Feb 28 2012
Arcadia Resources, Inc. , a leading provider of innovative consumer health care under the Arcadia HealthCare brand has announced plans to WellPoint, Inc. affiliate to offer the health of its members in Kansas the opportunity to enroll in DailyMed Pharmacy Program Arcadia earlier this month.
Posted in Articles by admin - Feb 27 2012
Newly issued guidelines to involve communities in HIV prevention research at the International Conference on AIDS Exit
Posted in Pharmacist Daily by admin - Feb 27 2012
The second edition of The Good Practice participatory project guidelines for biomedical prevention trials were released at the International Conference in Vienna by AVAC. The GPP guidelines are intended to provide proof of donors, sponsors, and artists with systematic guidance on how to work effectively with a range of stakeholders to design and conduct biomedical HIV prevention trials.
‘The discoveries of molecular genetics can make child psychiatry on the eve of a revolution’, Alan Zametkin, MD, tells WebMD in an interview seeking objective analysis of the latest genetic research. ‘We have no conclusions about the genetics of ADHD regarding the diagnosis and treatment yet, and we should not expect to see the results of this in the next two years. However, five years from now, the studies that are now in progress may lead to such discoveries. ‘
The book seems to have had a stronger effect on both tanning reasons: a great tan and opiates as unhappy with your natural skin tone. The effect was not so obvious for two reasons: to feel one’s tan out of control and having a tolerance to tanning. The results were published in the May issue of Archives of Dermatology.
Posted in Articles by admin - Feb 23 2012
Posted in Pharmacy practice by admin - Feb 22 2012
Imagine your joy as you enjoy your favorite foods of Mexico could be a full load bean burrito topped with a wide range of thin slices of peppers jalepe o. What happens when you bite into a little ‘pepper in more than he bargained for? It is thought to drive away the thought of a little ‘heat? Maybe even a little ’sweat on the forehead? In fact, scientists can say that eating hot peppers contain a substance called capsaicin, which not only adds flavor to our food, but can actually cause your body to warm up. Instead, the kitchens around the world rely on capsaicin box to add the peppers and pungent zing to many foods, and ‘pepperheads’ often choose their meal plan to turn up the heat. But scientists are learning that there is more than it seems when it comes to peppers. In fact, there is increasing evidence that the power of the body generates heat of peppers may also help in our quest to lose those extra inches accumulate around our collective national life. And luckily for those of us who do not ‘burn’ chili, there are plants that are non-firing version of dihydrocapsiate called capsaicin , which could have benefits without spicy peppers.
Publisher Lippincott Williams & Wilkins announces partnership with Laerdal Medical to develop simulations of nursing skills
Posted in Pharmacist Daily by admin - Feb 21 2012
Competent nurses are essential to patient safety and optimal results for patients. The Lippincott / Laerdal simulators allow nursing students to experience real-world scenarios that correspond to their course of care, to build capacity and strengthen the critical thinking skills. Nurses increase their knowledge base with clinical scenarios that fit their specialty.
Gestational diabetes can be predicted seven years before pregnancy with a blood glucose and body weight, study suggests
Posted in ED Pills by admin - Feb 20 2012
Although established risk factors for GDM were older maternal age, obesity, non-white race / ethnicity, giving birth to a child already very large and a family history of diabetes, these risk factors are absent in most half of women who develop gestational diabetes. This study is important because it gives a better understanding of pre-pregnancy predictors of GDM may help identify women at risk and placed in intervention programs before pregnancy to prevent GDM and its associated risks, according to researchers.
Posted in Articles by admin - Feb 20 2012
NOX-E36 is a Spiegelmer new therapy that specifically binds and inhibits chemokines monocyte chemotactic pro-inflammatory protein-1 , which is also known as CCL2. Studies already performed in animal models of diabetes and nephropathy showed that treatment with MCP-1 antagonists Spiegelmer significantly delay the decline of renal function and progression of the disease. Single phase I trial showed the dose upward NOX-E36 to be safe and well tolerated in healthy volunteers at all doses used after both intravenous and subcutaneous administration. Bioavailability by subcutaneous administration of NOX-E36 was higher than 50 percent. A comprehensive comparison between NOX-E36 and placebo subjects showed no differences in safety. There were no clinically significant effects on vital signs, ECG and laboratory parameters. NOX-E36 exhibited dose-linear pharmacokinetics and the pharmacokinetic profile after subcutaneous administration, suggests the possibility to maintain plasma concentrations to be clinically relevant dose once or twice a week. Pharmacodynamic data showed a significant dose-dependent reduction in peripheral blood monocytes – the largest population of immune cells bearing the MCP-1 receptor. Preclinical profile and the first in-human studies were supported by a grant from the German Federal Ministry of Education and Research .
Posted in Detoxification by admin - Feb 19 2012
Dr. Sampson will remain principal investigator of the five original sites Cofares: The Mount Sinai Medical Center, Duke University Medical Center, Johns Hopkins University, National Jewish Health in Denver, and University of Arkansas for Medical Sciences. Cofares currently recruiting patients for studies evaluating the treatment of oral peanut protein and all the patches.